Bluejay Diagnostics, Inc.
BJDX
$1.17
-$0.05-4.10%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.46% | -1.50% | -15.06% | -19.58% | -16.47% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.58% | -25.75% | -34.09% | -30.47% | -22.22% |
| Operating Income | 13.58% | 25.75% | 34.09% | 30.47% | 22.22% |
| Income Before Tax | 20.24% | 28.39% | 25.54% | 22.46% | 14.43% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 20.24% | 28.39% | 25.54% | 22.46% | 14.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.24% | 28.39% | 25.54% | 22.46% | 14.43% |
| EBIT | 13.58% | 25.75% | 34.09% | 30.47% | 22.22% |
| EBITDA | 13.56% | 23.93% | 31.07% | 26.58% | 17.77% |
| EPS Basic | 56.32% | -- | -- | -- | -- |
| Normalized Basic EPS | -9.72% | -- | -- | -- | -- |
| EPS Diluted | 56.32% | -- | -- | -- | -- |
| Normalized Diluted EPS | -9.72% | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 2,015.38% | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 2,015.38% | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |